"The U.S. Food and Drug Administration today approved Dalvance (dalbavancin), a new antibacterial drug used to treat adults with skin infections.
Dalvance is intended to treat acute bacterial skin and skin structure infections (ABSSSI) cau"...
- Patient Information:
Details with Side Effects
The patient should be told to:
- Avoid the use of occlusive dressings or wrappings unless otherwise directed by the physician.
- Keep Naftin® (naftifine) Gel, 1% away from the eyes, nose, mouth and other mucous membranes.
Last reviewed on RxList: 6/11/2008
This monograph has been modified to include the generic and brand name in many instances.
Additional Naftin Gel Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.